Jan 23, 2023
Big Pharma company Johnson & Johnson (J&J) has announced that it has discontinued the creation of an HIV vaccine after a large clinical trial found that the experimental treatment was not effective at preventing infections. The trial in question was a phase 3 clinical trial - known as the Mosaico trial - J&J had organized along with the National Institute of Allergy and Infectious Diseases, the HIV Vaccine Trials Network and the United States Army's Medical Research and Development Command. The trial enrolled 3,900 volunteers at over 50 sites in multiple countries and studied the effect of the vaccine in gay men and transgender people, two groups that are considered more vulnerable to HIV. (Related: JABBED UNTIL DEATH: Endless mRNA jabs are now planned for multiple vaccine types, including influenza, HIV, RSV, Pneumococcal, Zika and many more.) The trial's failure marks yet another setback in J&J's search for a vaccine against a virus that can rapidly mutate